mos Health (US:COSM) Globenewswire·2026-02-19 16:30Core Insights - Cosmos Health Inc. is evaluating strategic monetization options for its real estate portfolio to unlock shareholder value, highlighting the intrinsic value of its assets [1][14] Real Estate Valuation - The combined fair market value of the Company's Cana Laboratories manufacturing facility and CosmoFarm logistics center is estimated at approximately $15 million, excluding machinery and equipment [2] - The estimated value is supported by favorable macro conditions in the Greek property market, with residential property prices surpassing their 2008 pre-financial crisis peak [3] - The fair market value of the Company's real estate assets exceeds its current market capitalization of approximately $13.5 million as of February 17, 2026 [4] Property Details - Cana Laboratories is located in Neo Iraklio, Athens, comprising approximately 54,000 square feet of land and 35,700 square feet of constructed area, with potential for additional buildable capacity [7] - The property is strategically located with access to major highways and proximity to Athens International Airport and commercial centers [8] - CosmoFarm Logistics Center in Peristeri, Athens, consists of approximately 29,100 square feet and operates as a pharmaceutical wholesale and distribution hub [11] Strategic Options - The Company's market capitalization reflects a significant discount to its reported book value of $23.1 million as of Q3 2025, indicating substantial capital relative to its public equity value [12] - Potential monetization strategies include outright sale, joint ventures, sale-leaseback transactions, or other arrangements, with proceeds potentially used for debt reduction or reinvestment [13] - The CEO emphasized the disconnect between the current valuation and the intrinsic value of the assets, indicating a focus on evaluating monetization opportunities carefully [14]